AAAAAA

   
Results: 1-13 |
Results: 13
Central clinical research issues in electrophysiology: Report of the NASPECommittee
Authors: Domanski, MJ Zipes, DP Benditt, DG Camm, AJ Exner, DV Ezekowitz, MD Greene, HL Lesh, MD Miller, JM Pratt, CM Saksena, S Scheinman, MM Singh, BN Tracy, CM Waldo, AL
Citation: Mj. Domanski et al., Central clinical research issues in electrophysiology: Report of the NASPECommittee, PACE, 24(4), 2001, pp. 526-534
Hemodynamic effects of tezosentan, an intravenous dual endothelin receptorantagonist, in patients with class III to IV congestive heart failure
Authors: Torre-Amione, G Young, JB Durand, JB Bozkurt, B Mann, DL Kobrin, I Pratt, CM
Citation: G. Torre-amione et al., Hemodynamic effects of tezosentan, an intravenous dual endothelin receptorantagonist, in patients with class III to IV congestive heart failure, CIRCULATION, 103(7), 2001, pp. 973-980
New therapeutic options in the management of claudication - Introduction
Authors: Pratt, CM Comerota, AJ
Citation: Cm. Pratt et Aj. Comerota, New therapeutic options in the management of claudication - Introduction, AM J CARD, 87(12A), 2001, pp. 1D-2D
Analysis of the cilostazol safety database
Authors: Pratt, CM
Citation: Cm. Pratt, Analysis of the cilostazol safety database, AM J CARD, 87(12A), 2001, pp. 28D-33D
Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia
Authors: He, ZX Hedrick, TD Pratt, CM Verani, MS Aquino, V Roberts, R Mahmarian, JJ
Citation: Zx. He et al., Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia, CIRCULATION, 101(3), 2000, pp. 244-251
Predicting antiarrhythmic performance
Authors: Pratt, CM
Citation: Cm. Pratt, Predicting antiarrhythmic performance, J CARD ELEC, 10(2), 1999, pp. 302-306
Evaluation of antiarrhythmic drug efficacy in patients with an ICD: Unlimited potential or replete with complexity and problems?
Authors: Pratt, CM Camm, AJ Bigger, JT Breithardt, G Campbell, RWF Epstein, AE Kappenberger, LJ Kuck, KH Pocock, S Saksena, S Waldo, AL
Citation: Cm. Pratt et al., Evaluation of antiarrhythmic drug efficacy in patients with an ICD: Unlimited potential or replete with complexity and problems?, J CARD ELEC, 10(11), 1999, pp. 1534-1549
Factors influencing clinical outcomes after revascularization in the asymptomatic cardiac ischemia pilot (ACIP)
Authors: Pepine, CJ Bourassa, MG Chaitman, BR Davies, RF Kerensky, RA Sharaf, B Knatterud, GL Forman, SA Pratt, CM Staples, ED Sopko, G Conti, CR
Citation: Cj. Pepine et al., Factors influencing clinical outcomes after revascularization in the asymptomatic cardiac ischemia pilot (ACIP), J CARDIAC S, 14(1), 1999, pp. 1-8
Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial
Authors: Richardson, DW Cobb, LA Pratt, CM Anderson, JL Ehlert, F Epstein, AE Flynn, D Greene, HL Hallstrom, AP Kim, S Klevan, LR Moore, R Mounsey, P Pratt, CM Richardson, DW Schron, E
Citation: Dw. Richardson et al., Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial, J AM COL C, 34(5), 1999, pp. 1552-1559
Evaluation of antiarrhythmic drug efficacy in patients with an ICD - Unlimited potential or replete with complexity and problems?
Authors: Pratt, CM Camm, AJ Bigger, JT Breithardt, G Campbell, RWF Epstein, AE Kappenberger, LJ Kuck, KH Pocock, S Saksena, S Waldo, AL
Citation: Cm. Pratt et al., Evaluation of antiarrhythmic drug efficacy in patients with an ICD - Unlimited potential or replete with complexity and problems?, EUR HEART J, 20(21), 1999, pp. 1538-1552
Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study)
Authors: Pepine, CJ Mark, DB Bourassa, MG Chaitman, BR Davies, RF Knatterud, GL Forman, S Pratt, CM Sopko, G Conti, CR
Citation: Cj. Pepine et al., Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study), AM J CARD, 84(11), 1999, pp. 1311-1316
Prolonged QTc time and ventricular arrhythmia with fexofenadine - Reply
Authors: Pratt, CM
Citation: Cm. Pratt, Prolonged QTc time and ventricular arrhythmia with fexofenadine - Reply, AM J CARD, 84(10), 1999, pp. 1279-1279
Cardiovascular safely of fexofenadine HCl
Authors: Pratt, CM Mason, J Russell, T Reynolds, R Ahlbrandt, R
Citation: Cm. Pratt et al., Cardiovascular safely of fexofenadine HCl, AM J CARD, 83(10), 1999, pp. 1451-1454
Risultati: 1-13 |